Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Androgen Deprivation Therapy (ADT) Market, by Drug Class, 2017-2026 (USD Billion)
1.2.2. Androgen Deprivation Therapy (ADT) Market, by Route of Administration, 2017-2026 (USD Billion)
1.2.3. Androgen Deprivation Therapy (ADT) Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.4. Androgen Deprivation Therapy (ADT) Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Androgen Deprivation Therapy (ADT) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Androgen Deprivation Therapy (ADT) Market Dynamics
3.1. Androgen Deprivation Therapy (ADT) Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Androgen Deprivation Therapy (ADT) Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Androgen Deprivation Therapy (ADT) Market, by Drug Class
5.1. Market Snapshot
5.2. Global Androgen Deprivation Therapy (ADT) Market by Drug Class, Performance - Potential Analysis
5.3. Global Androgen Deprivation Therapy (ADT) Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)
5.4. Androgen Deprivation Therapy (ADT) Market, Sub Segment Analysis
5.4.1. Antiandrogens
5.4.2. LHRH Agonists
5.4.3. LHRH Antagonist
5.4.4. Others
Chapter 6. Global Androgen Deprivation Therapy (ADT) Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Androgen Deprivation Therapy (ADT) Market by Route of Administration, Performance - Potential Analysis
6.3. Global Androgen Deprivation Therapy (ADT) Market Estimates & Forecasts by Route of Administration, 2016-2026 (USD Billion)
6.4. Androgen Deprivation Therapy (ADT) Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
Chapter 7. Global Androgen Deprivation Therapy (ADT) Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Androgen Deprivation Therapy (ADT) Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Androgen Deprivation Therapy (ADT) Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)
7.4. Androgen Deprivation Therapy (ADT) Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Androgen Deprivation Therapy (ADT) Market, Regional Analysis
8.1. Androgen Deprivation Therapy (ADT) Market, Regional Market Snapshot
8.2. North America Androgen Deprivation Therapy (ADT) Market
8.2.1. U.S. Androgen Deprivation Therapy (ADT) Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2016-2026
8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Androgen Deprivation Therapy (ADT) Market
8.3. Europe Androgen Deprivation Therapy (ADT) Market Snapshot
8.3.1. U.K. Androgen Deprivation Therapy (ADT) Market
8.3.2. Germany Androgen Deprivation Therapy (ADT) Market
8.3.3. Rest of Europe Androgen Deprivation Therapy (ADT) Market
8.4. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Snapshot
8.4.1. China Androgen Deprivation Therapy (ADT) Market
8.4.2. India Androgen Deprivation Therapy (ADT) Market
8.4.3. Japan Androgen Deprivation Therapy (ADT) Market
8.4.4. Rest of Asia Pacific Androgen Deprivation Therapy (ADT) Market
8.5. Latin America Androgen Deprivation Therapy (ADT) Market Snapshot
8.5.1. Brazil Androgen Deprivation Therapy (ADT) Market
8.5.2. Mexico Androgen Deprivation Therapy (ADT) Market
8.6. Rest of The World Androgen Deprivation Therapy (ADT) Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject To Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Astellas Pharma Inc.
9.2.3. Johnson & Johnson
9.2.4. Novartis International AG
9.2.5. Veru Inc.
9.2.6. Sanofi S.A.
9.2.7. GlaxoSmithKline plc
9.2.8. Bayer AG
9.2.9. Orion Corporation
9.2.10. AstraZeneca Plc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



List of Figures


FIG 1. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, KEY TRENDS 2018
FIG 5. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, PEST ANALYSIS
FIG 8. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 19. NORTH AMERICA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET 2016 & 2026 (USD BILLION)
FIG 20. EUROPE ANDROGEN DEPRIVATION THERAPY (ADT) MARKET 2016 & 2026 (USD BILLION)
FIG 21. ASIA PACIFIC ANDROGEN DEPRIVATION THERAPY (ADT) MARKET 2016 & 2026 (USD BILLION)
FIG 22. LATIN AMERICA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET 2016 & 2026 (USD BILLION)
FIG 23. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, COMPANY MARKET SHARE ANALYSIS (2018)


List of Tables


TABLE 1. LIST OF SECONDARY SERVICES, USED IN THE STUDY OF GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET
TABLE 2. LIST OF PRIMARY SERVICES, USED IN THE STUDY OF GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET
TABLE 3. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD BILLION)
TABLE 8. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY ROUTE OF ADMINISTRATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
TABLE 10. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. U.S. ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. U.S. ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. U.S. ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. U.S. ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. CANADA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. CANADA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CANADA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CANADA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. UK ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. UK ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. UK ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. UK ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. GERMANY ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. GERMANY ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. GERMANY ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. GERMANY ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROE ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROE ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROE ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. ROE ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. CHINA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49. CHINA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. CHINA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. CHINA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. INDIA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. INDIA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. INDIA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. INDIA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. JAPAN ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. JAPAN ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. JAPAN ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. JAPAN ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. ROAPAC ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 61. ROAPAC ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62. ROAPAC ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROAPAC ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. BRAZIL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 65. BRAZIL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 66. BRAZIL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 67. BRAZIL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 68. MEXICO ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 69. MEXICO ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 70. MEXICO ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 71. MEXICO ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 72. ROLA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 73. ROLA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 74. ROLA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 75. ROLA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 76. ROW ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 77. ROW ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 78. ROW ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 79. ROW ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)